BT and Exostar to Help Life Sciences Organizations Collaborate Securely and
Scientists engaged in collaborative initiatives can now securely access
Transformative Cloud-based solution
IRVING, Texas -- April 29, 2014
BT and Exostar, LLC announced today that Exostar is joining the BT for Life
Sciences ecosystem as a Strategic Member. The two companies will be working
closely together to enable Exostar’s federated identity solutions to ensure
life sciences organizations receive seamless, secure access to the BT for Life
Sciences cloud compute platform.
Health datasets are increasingly used in drug development, clinical trials and
health analytics. In addition, new legislation means that pharmaceutical
companies need to give stakeholder access to clinical trials data, which are
often sensitive. BT for Life Sciences has already launched solutions which
provide scientists easy and effective access to the rich sources of
information, based on its innovative cloud-based infrastructure. These are
available today on a global basis.
The next step in the BT for Life Sciences evolution brings a leading
industry-standard method of securing access to these solutions and associated
information, enabling a secure ecosystem approach to life sciences
collaboration. To take that next step, BT for Life Sciences is teaming with
Exostar, a leading provider of cloud-based identity and access management
solutions for the life sciences industry. Ecosystem users may be ‘in-house’
employees, come from collaborative organizations involved in drug research and
development, or from other agencies such as regulators.
BT and Exostar aim to deliver a joint proposition that leverages their
respective capabilities to address the secure, federated collaboration
challenges of the life sciences market. Exostar will be providing their
cloud-based identity and access management solution suite, anchored by the
Exostar Life Sciences Identity Hub. Organizations connect once to the Identity
Hub, which provides them with trusted pathways to the assets of all of their
partners in the community, and vice versa. Individuals benefit from a single
sign-on user experience that allows them to use one credential to access the
applications and information they need to collaborate productively and
The combination of BT for Life Sciences, the BT Cloud Compute platform, and
Exostar’s Life Sciences Identity Hub aims to permit easy, rapid and safe
access to existing solutions. It will also enable the future development of
virtual ‘scientist workbenches’ tailored to various disciplines such as
Bioinformatics and Cheminformatics. The mutual goal of both companies is to
let the scientist focus on the science and not have to worry about the
complexities of secure information management, particularly in a cloud
environment that crosses enterprise boundaries.
“BT and Exostar have complementary service offerings whose combination
delivers exceptional value to life sciences organizations,” said Vijay
Takanti, Exostar’s Vice President of Security and Collaboration. “The pairing
of BT’s global life sciences solution platform with Exostar’s expertise in
deploying cloud-based federated identity solutions to the life sciences
community is a force multiplier that will accelerate time-to-market for
life-saving drugs, therapies, and treatments that save lives.”
Yury Rozenman, Business Development Director, BT for Life Sciences, said,
“Building on the launch of BT for Life Sciences in 2012, we are excited that
our collaboration with Exostar is bringing new innovations to the Life
Sciences industry. By making it easier for scientists to collaborate securely
when working with sensitive data and systems, we can help to enable
transformative approaches to healthcare. Working together, BT and Exostar are
giving scientists efficient and cost-effective access to truly empowering
technologies, whilst respecting the security and confidentiality challenges
that they face.”
BT is one of the world’s leading providers of communications services and
solutions, serving customers in more than 170 countries. Its principal
activities include the provision of networked IT services globally; local,
national and international telecommunications services to its customers for
use at home, at work and on the move; broadband, TV and internet products and
services; and converged fixed/mobile products and services.BT consists
principally of five lines of business: BT Global Services, BT Business, BT
Consumer, BT Wholesale and Openreach.
For the year ended 31 March 2013, BT Group’s reported revenue was £18,103m ^
with reported profit before taxation of £2,315m.
British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group
plc and encompasses virtually all businesses and assets of the BT Group.BT
Group plc is listed on stock exchanges in London and New York.
For more information, visit www.btplc.com.
Exostar powers secure business-to-business information sharing, collaboration
and business process integration throughout the value chain. Exostar supports
the complex trading needs of many of the world's largest companies in
aerospace and defense, life sciences, and other industries. Exostar’s
cloud-based identity assurance products and business applications reduce risk,
improve agility and strengthen trading partner relationships and profitability
for over 100,000 companies in 150 countries worldwide. The Exostar community
includes market leaders such as AstraZeneca, BAE Systems, Bell Helicopter, The
Boeing Company, BT, Computer Sciences Corporation, Lockheed Martin Corp.,
Merck, Newport News Shipbuilding, Northrop Grumman, Raytheon Co. and
Rolls-Royce. For more information, please visit www.exostar.com.
Head of PR and Corporate Relations U.S.
Press spacebar to pause and continue. Press esc to stop.